Alpha 2.0
Login Register
» Articles » PMID: 4334086

Clinical Trials with the Antitumor Agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide(NSC-45388)

Overview
Journal Cancer Chemother Rep
Specialties Oncology
Pharmacology
Date 1970 Apr 1
PMID 4334086
Citations 8
Authors
J K LUCE
W G THURMAN
B L ISAACS
R W TALLEY
Affiliations
Soon will be listed here.
Citing Articles

Prognostic nomogram for external ear melanoma patients in the elderly: a SEER-based study.

Gong X, Zhang Y, Yuan M, Wang Y, Xia C, Wang Y J Cancer Res Clin Oncol. 2023; 149(13):12241-12248.

PMID: 37434093 DOI: 10.1007/s00432-023-05098-y.

Translating Molecules into Imaging-The Development of New PET Tracers for Patients with Melanoma.

Vercellino L, de Jong D, Dercle L, Hosten B, Braumuller B, Das J Diagnostics (Basel). 2022; 12(5).

PMID: 35626272 PMC: 9139963. DOI: 10.3390/diagnostics12051116.

State of melanoma: an historic overview of a field in transition.

Gorantla V, Kirkwood J Hematol Oncol Clin North Am. 2014; 28(3):415-35.

PMID: 24880939 PMC: 4040458. DOI: 10.1016/j.hoc.2014.02.010.

A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors.

Adkins D, Irvin R, Kuhn J, Boldt D, Roodman G, Salzman D Invest New Drugs. 1993; 11(2-3):169-79.

PMID: 8262729 DOI: 10.1007/BF00874151.

Chemotherapy of malignant melanoma with dimethyl traizeno imidazole carboxamide (DITC) and nitrosourea derivatives (BCNU, CCNU).

HILL 2nd G, Ruess R, BERRIS R, PHILPOTT G, Parkin P Ann Surg. 1974; 180(2):167-74.

PMID: 4601984 PMC: 1343633. DOI: 10.1097/00000658-197408000-00007.